Skip to main content

Table 4 Outcomes inRTRs and nonRTRs

From: COVID-19 in renal transplant recipients and general population: a comparative study of clinical, laboratory, and radiological features, severity, and outcome

  Group P
Transplant Pts Non-Transplant Pts
Count (N %) Count (N %)
Duration of hospitalization 9.83 ± 7.29, 7.50(4.00–15.00) 8.62 ± 6.63, 6.00(4.00–11.00) 0.556
Discharge status Discharge 18 (75.0) 35 (87.5) 0.173
Expired 6 (25.0) 5 (12.5)  
Severity Mild 0 (0.0) 0 (0.0) 0.524
Moderate 7 (29.2) 10 (25.0)  
Sever 8 (33.3) 11 (47.5)  
Critical 9 (37.5) 19 (27.5)  
ICU admission No 15 (65.2) 27 (73.0) 0.524
Yes 8 (34.8) 10 (27.0)  
Ventilation type No ventilation 0 (0.0) 5 (13.2) 0.068
Nasal o2 or mask 14 (63.6) 23 (60.5)  
NIV 2 (9.1) 6 (15.8)  
MV 6 (27.3) 4 (10.5)  
O2satatadmission   90.74 ± 8.47(93.00(88.00–96.00)) 89.26 ± 6.32(90.00(85.00–95.00)) 0.148
RR at admission   19.70 ± 3.57(20.00(18.00–20.00)) 19.49 ± 2.42(19.00(18.00–20.00)) 0.940
  1. Mean ± SD(MED(p25-p75))